SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE. RMSR [Internet]. 2025 Jan. 11 [cited 2025 Apr. 30];3(1):522-31. Available from: http://www.thermsr.com/index.php/Journal/article/view/403